Biogen Gets Rights For MS Pill Outside US - Bloomberg
460 views · Published 1 July 2009 · 0:42 · Indexed 20 September 2026
Channel: Bloomberg Originals · 2009 · News & Politics
Biogen pays half a billion dollars to market M.S. pills outside the U.S. It is designed to help walking conditions in patients with multiple sclerosis. (Bloomberg News)
More from this channel
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg
-
1:01
Broadway At Tony Awards - Bloomberg